Literature DB >> 16305417

Intranasal drug delivery for brain targeting.

Tushar K Vyas1, Aliasgar Shahiwala, Sudhanva Marathe, Ambikanandan Misra.   

Abstract

Many drugs are not being effectively and efficiently delivered using conventional drug delivery approach to brain or central nervous system (CNS) due to its complexity. The brain and the central nervous system both have limited accessibility to blood compartment due to a number of barriers. Many advanced and effective approaches to brain delivery of drugs have emerged in recent years. Intranasal drug delivery is one of the focused delivery options for brain targeting, as the brain and nose compartments are connected to each other via the olfactory route and via peripheral circulation. Realization of nose to brain transport and the therapeutic viability of this route can be traced from the ancient times and has been investigated for rapid and effective transport in the last two decades. Various models have been designed and studied by scientists to establish the qualitative and quantitative transport through nasal mucosa to brain. The development of nasal drug products for brain targeting is still faced with enormous challenges. A better understanding in terms of properties of the drug candidate, nose to brain transport mechanism, and transport to and within the brain is of utmost importance. This review will discuss some pertinent issues to be considered and challenges to brain targeted intranasal drug delivery. A few marketed and investigational drug formulations will also be discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16305417     DOI: 10.2174/1567201053586047

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  28 in total

1.  Intranasal delivery--modification of drug metabolism and brain disposition.

Authors:  Yin Cheong Wong; Zhong Zuo
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

2.  First Steps to Develop and Validate a CFPD Model in Order to Support the Design of Nose-to-Brain Delivered Biopharmaceuticals.

Authors:  Lucas Engelhardt; Martina Röhm; Chrystelle Mavoungou; Katharina Schindowski; Annette Schafmeister; Ulrich Simon
Journal:  Pharm Res       Date:  2016-02-17       Impact factor: 4.200

3.  Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.

Authors:  Gregory Kaler; David M Truong; Akash Khandelwal; Megha Nagle; Satish A Eraly; Peter W Swaan; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2007-06-05       Impact factor: 5.157

Review 4.  Drug delivery systems, CNS protection, and the blood brain barrier.

Authors:  Ravi Kant Upadhyay
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

5.  Intranasal delivery of deferoxamine reduces spatial memory loss in APP/PS1 mice.

Authors:  Leah R Hanson; Jared M Fine; Dan B Renner; Aleta L Svitak; Rachel B Burns; Thuhien M Nguyen; Nathan J Tuttle; Dianne L Marti; S Scott Panter; William H Frey
Journal:  Drug Deliv Transl Res       Date:  2012-06       Impact factor: 4.617

6.  Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan.

Authors:  Tushar K Vyas; A K Babbar; R K Sharma; Shashi Singh; Ambikanandan Misra
Journal:  AAPS PharmSciTech       Date:  2017-03-08       Impact factor: 3.246

7.  Intranasal Zotepine Nanosuspension: intended for improved brain distribution in rats.

Authors:  Sravanthi Reddy Pailla; Sreekanth Talluri; Nagarjun Rangaraj; Ramdas Ramavath; Veerabhadra Swamy Challa; Nandkumar Doijad; Sunitha Sampathi
Journal:  Daru       Date:  2019-06-29       Impact factor: 3.117

8.  Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay.

Authors:  M R Lee; K B Scheidweiler; X X Diao; F Akhlaghi; A Cummins; M A Huestis; L Leggio; B B Averbeck
Journal:  Mol Psychiatry       Date:  2017-03-14       Impact factor: 15.992

9.  Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.

Authors:  Gitanjali Sharma; Anil Kumar Mishra; Pushpa Mishra; Ambikanandan Misra
Journal:  AAPS PharmSciTech       Date:  2009-11-06       Impact factor: 3.246

10.  Vessel microport technique for applications in cerebrovascular research.

Authors:  Lei Chen; Karin R Swartz; Michal Toborek
Journal:  J Neurosci Res       Date:  2009-05-15       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.